More Articles Back to Article
J&J finishes enrollment for Phase 3 COVID-19 vaccine trials
Johnson & Johnson has fully enrolled the late-stage trials for its COVID-19 vaccine candidate with 45,000 participants. The company also disclosed that the vaccine has the potential to be given in one injection and will not require ultra-cold storage. WBTS-TV (Boston) (12/20)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!